Journal article
Drug interventions for prevention of COVID-19 progression to severe disease in outpatients: a systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
Abstract
OBJECTIVES: To assess the effects of interventions authorised by the European Medicines Agency (EMA) or the US Food and Drug Administration (FDA) for prevention of COVID-19 progression to severe disease in outpatients.
SETTING: Outpatient treatment.
Authors
Petersen JJ; Jørgensen CK; Faltermeier P; Siddiqui F; Feinberg J; Nielsen EE; Kristensen AT; Juul S; Holgersson J; Nielsen N
Journal
BMJ Open, Vol. 13, No. 6,
Publisher
BMJ
Publication Date
June 2023
DOI
10.1136/bmjopen-2022-064498
ISSN
2044-6055